from Reuters: U.S. http://ift.tt/2FyfvsD
//
Impax to pay $35 million to settle part of Solodyn antitrust litigation
March 11, 2018 / / in Reuters: U.S. / with No comments /
BOSTON (Reuters) - Impax Laboratories Inc has agreed to pay $35 million to resolve part of litigation over claims it entered into an anticompetitive deal in a patent case to delay releasing a generic version of the acne medication Solodyn.
from Reuters: U.S. http://ift.tt/2FyfvsD
//
from Reuters: U.S. http://ift.tt/2FyfvsD
//
Related Posts:
U.S. greenhouse emissions fell in 2017 as coal plants shut- Florida's Republicans feel brunt of hurricane in upcoming election
- Utah man indicted over ricin mail threat to Trump, others
- Former USA Gymnastics boss arrested for Nassar evidence-tampering
- Trump administration asks high court to halt climate change case
0 comments:
Post a Comment